Stage-directed individualized therapy in esophageal cancer

Publication date

2016-10-01

Authors

Goense, Lucas
van Rossum, Peter
Kandioler, Daniela
Ruurda, JelleORCID 0000-0001-6584-1677ISNI 0000000397120932
Goh, Khean Lee
Luyer, Misha D.
Krasna, Mark J.
van Hillegersberg, RichardORCID 0000-0002-7134-261XISNI 0000000387532685

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

Esophageal cancer is the eighth most common cancer worldwide, and the incidence of esophageal carcinoma is rapidly increasing. With the advent of new staging and treatment techniques, esophageal cancer can now be managed through various strategies. A good understanding of the advances and limitations of new staging techniques and how these can guide in individualizing treatment is important to improve outcomes for esophageal cancer patients. This paper outlines the recent progress in staging and treatment of esophageal cancer, with particularly attention to endoscopic techniques for early-stage esophageal cancer, multimodality treatment for locally advanced esophageal cancer, assessment of response to neoadjuvant treatment, and the role of cervical lymph node dissection. Furthermore, advances in robot-assisted surgical techniques and postoperative recovery protocols that may further improve outcomes after esophagectomy are discussed.

Keywords

anastomotic leakage, esophageal cancer, esophageal surgery, neoadjuvant chemoradiation, robot-assisted, tumor staging, General Biochemistry,Genetics and Molecular Biology, History and Philosophy of Science, Journal Article, Review

Citation

Goense, L, van Rossum, P S N, Kandioler, D, Ruurda, J P, Goh, K L, Luyer, M D, Krasna, M J & van Hillegersberg, R 2016, 'Stage-directed individualized therapy in esophageal cancer', Annals of the New York Academy of Sciences, vol. 1381, no. 1, pp. 50-65. https://doi.org/10.1111/nyas.13113